摘要
目的：观察依达拉奉联合奥扎格雷钠治疗急性脑梗塞的临床疗效。方法：选择急性脑梗塞病例90例，随机分为对照组和观察组，治疗前后对患者进行欧洲卒中评分（ESS），日常生活能力（ADL）及C-反应蛋白（CRP）的测定。结果：观察组ESS和ADL有显著升高（P〈0．01，P〈0．05），CRP有显著下降（P〈0．05），对照组的各项指标较治疗前无明显变化。结论：依达拉奉联合奥扎格雷钠治疗急性脑梗塞的临床疗效显著。
Objective： To observe the joint ozagrel edaravone treatment of acute cerebral infaretion. Methods 90 patients with aeute cerebral infarction patients were randomly divided into control group and observation group, before and after treatment the patients were European stroke scale （ESS）, activities of daily living （ADL） and C-reactive protein （CRP） determination. The results of ESS and ADL observation group were significantly higher （P 〈0.01, P 〈0.05）, CRP was significantly decreased （P 〈0.05）, the targets of the control group no significant changes than before. Conclusion ozagrel edaravone treatment of acute cerebral infarction combined clinical effect is significant.
